New-Onset Diabetes After Acute and Critical Illness

• Published in: Mayo Clinic proceedings Vol. 92; no. 5; pp. 762 - 773
• Main Authors: Jivanji, Chirag J., MHSc, Asrani, Varsha M., MHSc, Windsor, John A., MBChB, MD, Petrov, Maxim S., MD, MPH, PhD
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.05.2017
• Subjects: Internal Medicine; nuclear factor-κβ; short-chain fatty acid; SAP; mild hyperglycemia; myocardial infarction; NF-kB; plasma glucose; normoglycemia; acute coronary syndrome; severe acute pancreatitis; STEMI; intensive care unit; MH; MI; AMI; heart failure; SCFA; ACS; PG; NG; American Diabetes Association; ICU; ST-segment elevation myocardial infarction; FPG; fasting plasma glucose; ADA; acute myocardial infarction; HF
• ISSN: 0025-6196; 1942-5546
• DOI: 10.1016/j.mayocp.2016.12.020

Abstract Hyperglycemia is commonly observed during acute and critical illness. Recent studies have investigated the risk of developing diabetes after acute and critical illness, but the relationship between degree of in-hospital hyperglycemia and new-onset diabetes has not been investigated. This study examines the evidence for the relationship between in-hospital hyperglycemia and prevalence of new-onset diabetes after acute and critical illness. A literature search was performed of the MEDLINE, EMBASE, and Scopus databases for relevant studies published from January 1, 2000, through August 4, 2016. Patients with no history of diabetes before hospital discharge were included in the systematic review. In-hospital glucose concentration was classified as normoglycemia, mild hyperglycemia, or severe hyperglycemia for the meta-analysis. Twenty-three studies were included in the systematic review, and 18 of these (111,078 patients) met the eligibility criteria for the meta-analysis. The prevalence of new-onset diabetes was significantly related to in-hospital glucose concentration and was 4% (95% CI, 2%-7%), 12% (95% CI, 9%-15%), and 28% (95% CI, 18%-39%) for patients with normoglycemia, mild hyperglycemia, and severe hyperglycemia, respectively. The prevalence of new-onset diabetes was not influenced by disease setting, follow-up duration, or study design. In summary, this study found stepwise growth in the prevalence of new-onset diabetes with increasing in-hospital glucose concentration. Patients with severe hyperglycemia are at the highest risk, with 28% developing diabetes after hospital discharge.